S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later

Mannatech (MTEX) Insider Trading & Ownership

$8.87
-0.20 (-2.21%)
(As of 02/26/2024 ET)

Mannatech (NASDAQ:MTEX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
53.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$15,601.94
Get MTEX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mannatech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MTEX Insider Buying and Selling by Quarter


Mannatech Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2023Larry A JobeDirectorSell1,217$12.82$15,601.94  
(Data available from 1/1/2013 forward)












MTEX Insider Trading Activity - Frequently Asked Questions

Who is on Mannatech's Insider Roster?

The list of insiders at Mannatech includes Alfredo Bala, Kevin Andrew Robbins, and Larry A Jobe. Learn more on insiders at MTEX.

What percentage of Mannatech stock is owned by insiders?

53.10% of Mannatech stock is owned by insiders. Learn more on MTEX's insider holdings.

Which Mannatech insiders have been selling company stock?

The following insiders have sold MTEX shares in the last 24 months: Alfredo Bala ($68,915.00), Kevin Andrew Robbins ($73,227.00), and Larry A Jobe ($15,601.94).

How much insider selling is happening at Mannatech?

Insiders have sold a total of 7,317 Mannatech shares in the last 24 months for a total of $157,743.94 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:MTEX) was last updated on 2/27/2024 by MarketBeat.com Staff